[1]景中民,朱海松,徐海亮,等.前列舒通胶囊联合盐酸坦索罗辛胶囊治疗湿热瘀阻型前列腺炎临床研究*[J].陕西中医,2019,(3):294-296.
　JING Zhongmin,ZHU Haisong,XU Hailiang,et al.Clinical reserach of Qianlie Shutong capsule combined with tamsulosin hydrochloride capsule in treating dampheat stagnation prostatitis[J].,2019,(3):294-296.
点击复制

前列舒通胶囊联合盐酸坦索罗辛胶囊治疗湿热瘀阻型前列腺炎临床研究*
分享到：

《陕西中医》[ISSN:1000-7369/CN:61-1281/TN]

卷:
期数:
2019年3
页码:
294-296
栏目:
临床研究
出版日期:
2019-03-05

文章信息/Info

Title:
Clinical reserach of Qianlie Shutong capsule combined with tamsulosin hydrochloride capsule in treating dampheat stagnation prostatitis
文章编号:
DOI: 10.3969/j.issn.10007369.2019.03.006
作者:
景中民; 朱海松; 徐海亮; 卢学仁
河南省驻马店市中心医院泌尿外科 (驻马店463000)
Author(s):
JING Zhongmin; ZHU Haisong; XU Hailiang ; et al.
Zhumadian Central Hospital in Henan Province （Zhumadian 463000）
关键词:
前列舒通胶囊; 湿热瘀阻; 前列腺炎; 盐酸坦索罗辛; 中西医结合疗法; 治疗应用
Keywords:
Key words Qianlie shutong capsule; Dampheat and stasis syndrome; Prostatitis; Tamsulosin hydrochloride; Integrated traditional chinese and western medicine therapy; Therapeutic application
分类号:
R697.33
文献标志码:
A
摘要:
摘 要 目的：探讨前列舒通胶囊联合盐酸坦索罗辛胶囊对于湿热瘀阻型前列腺炎的临床疗效。方法：利用随机数字分组方法，将96例湿热瘀阻型前列腺炎患者分成I组（48例）和II组（48例）。给予I组患者盐酸坦索罗辛胶囊单药治疗；II组在I组治疗基础上加前列舒通胶囊治疗方案，评估I、II组患者治疗前及治疗8周后：美国国立卫生研究院慢性前列腺炎症状评分量表(NIHCPSI)评分情况。前列腺液常规检查（卵磷脂小体数目、白细胞计数以及pH值）。综合评估I、II组患者临床总有效率情况。结果：I、II患者的NIHCPSI评分较治疗前均显著降低，生活质量提升，尿道不适症状显著改善，前列腺液常规检查明显趋于正常（P＜0.05）；但II组患者的NIHCPSI各项评分(包括疼痛评分、排尿症状评分、QOL评分)及前列腺液常规检查结果较I组恢复更为理想，II组临床总有效率91.67 %显著高于I组72.92 %（P均＜0.05）。结论：前列舒通胶囊联合盐酸坦索罗辛胶囊对于湿热瘀阻型前列腺炎临床治疗效果显著。
Abstract:
Abstract Objective: To investigate the clinical efficacy of qianlie shutong capsule combined with tamsulosin hydrochloride capsule in the treatment of prostatitis of dampheat and stasis syndrome. Methods: 96 patients with prostatitis of dampheat and stasis syndrome were divided into group I (48 cases) and group II (48 cases). Tamsulosin hydrochloride capsules were given to group I alone；group II was treated with qianlie shutong capsules on the basis of group I. The patients in group I and group II were evaluated before and after treatment for 8 weeks: National Institutes of Healthchronic prostatitis symptom index (NI) HCPSI score. Routine examination of prostatic fluid (number of lecithin corpuscles，white blood cell count and pH value). To evaluate the clinical total effective rate of group I and group II. Results: The NIHCPSI scores of patients with I and II were significantly lower than those before treatment，the quality of life was improved，the symptoms of urethral discomfort were significantly improved，and the routine examination of prostatic fluid tended to be normal (P＜0.05).However, the NIHCPSI scores of patients with II (including pain score，micturition symptom score，QOL score) and the routine examination of prostatic fluid nodules were significantly improved. The clinical total effective rate of group II 91.67% was significantly higher than that of group I 72.92% (P＜0.05). Conclusion: Qianlie shutong capsule combined with tamsulosin hydrochloride capsule is effective in treating prostatitis of dampheat and stasis syndrome.

参考文献/References:

[1] 强亚勇，张斌斌，白安胜，等.III型前列腺炎与感染相关性研究[J] .陕西医学杂志，2016，45(8):10441046. 
[2] 张阳光，孟凡钦.补肾化浊汤联合盐酸环丙沙星治疗慢性前列腺炎疗效及对炎症因子的影响[J] .现代中西医结合杂志，2016，25(21):23772379. 
[3] 罗建辉，蔡铜山.慢性前列腺炎排尿异常的研究进展[J] .现代中西医结合杂志，2013，22(23):26172619. 
[4] 轩立华.前列舒通胶囊治疗湿热瘀阻型前列腺炎[J] .吉林中医药，2015，31(9):914917. 
[5] 李晓阳，高旋慰.化浊通瘀汤配合直肠滴入治疗湿热瘀阻型前列腺炎84例[J] .陕西中医，2014，35(9):12051207. 
[6] 尤传静，吴 强.中药清浊汤对ⅢB型前列腺炎湿热瘀阻症患者SIgA、IL8、TNFα的影响[J] .中国男科学杂志，2017，31(2):4750. 
[7] 宋志君.慢性前列腺炎中医证候临床疗效评价域体系构成的相关探讨[J] .中国医药指南，2015，30(20):2323，24.
[8] 杨彩云，齐进春，薛文勇.前列舒通联合左氧氟沙星治疗慢性细菌性前列腺炎的临床疗效及安全性评价[J] .中国临床药理学杂志，2015，31(22):21872189. 
[9] 李世强，侯建平，智静涛，等.益肾通方联合坦索罗辛治疗肾虚血瘀型良性前列腺增生伴勃起功能障碍疗效观察[J] .现代中西医结合杂志，2018，27(27):30003003. 〖ZK)〗
[10] 周益军，戴晓农，朱喜山，等.祛瘀散寒中药联合坦索罗辛治疗CABP/CPPS疗效及对白细胞计数的影响[J] .现代中西医结合杂志，2018，27(12):13161319. 
[11] 裴景堂.骶管注射治疗Ⅲ型前列腺炎并发早泄60例分析[J] .陕西医学杂志，2009，38(1):8384. 
[12] 鲁 鹏，蒋迎春.利湿通淋中药联合左氧氟沙星治疗慢性前列腺炎疗效及对白细胞计数、卵磷脂小体水平的影响[J] .现代中西医结合杂志，2018，27(3):281284. 
[13] 阎 鹏.Ⅲ型慢性前列腺炎113例前列腺液中UA测定及其意义[J] .陕西医学杂志，2012，41(5):609610，626. 
[14] 李 阳，于 兰，刘 静.前列腺液中致病菌检出情况分析[J] .现代中西医结合杂志，2011，20(7):880. 
[15] 陈雪辉，张晓玲，吴雪芸.前列腺炎患者前列腺液检测分析[J] .现代中西医结合杂志，2002，11(15):1487. 
[16] 何新洲，王升晗，崔 波，等.湿热消汤联合银花泌炎灵片对前列腺炎患者IL1β、IL6和TNFα水平的影响[J] .陕西中医，2018，39(8):10801083. 
[17] 向 彬，雷光辉，张 旭，等.复方玄驹胶囊辅助西医治疗对慢性前列腺炎患者免疫功能及生活质量的影响[J] .陕西中医，2016，37(10):12971298. 
[18] 李嘉诚，吴 岚，蔡同凯，等.黄柏化学成分及其药理作用研究进展[J] .药学实践杂志，2018，36(5):389391，398.
[19] 宁 晶，张晓毅，邹 练.盐酸坦索罗辛胶囊联合宁泌泰胶囊治疗Ⅲ型前列腺炎的临床疗效分析[J] .中国性科学，2018，27(1):1417. 

备注/Memo

备注/Memo:
*河南卫生政策研究课题(YWZY201326)
更新日期/Last Update: 2019-03-13